logo
ProjectCompleted

Adv Bio-Extracts

One of 7,540 projects Taiyo tracks in Kenya.

Source: International Finance Corporation (IFC)

Advanced Bio-Extracts Limited (ABE or the company), along with its subsidiaries, is the pioneer and leading commercial producer of artemisinin in East Africa. The company is setting up production facilities to:- extract crude artemisinin from 6,600 TPA of Artemisia annua leaves by June 2007; and - using the crude artemisinin to process up to 50 TPA of pure artemisinin by April 2008. The project

Status
Closed
Sector
Commercial, Hospital, Government
Location
Kenya
Updated
22 Jul 2026
Source
International Finance Corporation (IFC)

ConstructChat

Ask ConstructChat about Adv Bio-Extracts

Pick a question to edit it, or write your own.

First answer free · no account

I am a

Project Information FAQ

Project Information

4 Q
The project “Adv Bio-Extracts” is an infrastructure initiative in the Commercial sector, located in Kenya. Taiyo aggregates data on it from International Finance Corporation (IFC).

Participants

Sponsoring Agency

Status

Original status

completed

Taiyo status

Closed

Taiyo last update

2026-07-22

Contact

Not available for this record.

Description

Description

Advanced Bio-Extracts Limited (ABE or the company), along with its subsidiaries, is the pioneer and leading commercial producer of artemisinin in East Africa. The company is setting up production facilities to:- extract crude artemisinin from 6,600 TPA of Artemisia annua leaves by June 2007; and - using the crude artemisinin to process up to 50 TPA of pure artemisinin by April 2008. The project is estimated to cost approximately $25.0 million and includes: - $12.4 million of capital expenditure;- $6.5 million of preoperative expenses (including technology development); and- $6.0 million for working capital financing. IFC’s proposed investment will be a combination of long-term debt and quasi-equity of up to $9 million, expected to be in the form of up to $6 million in an A loan and up to $3 million of a C loan for IFC’s own account.The company started commercial production, at a limited scale, in October 2005. Once the artemisinin production is well established, the company plans to diversify into the production of artemisinin- based derivatives and other plant-based extracts, some of which are related to the pharmaceutical industry.

Original sector

FA - Pharmaceuticals and Medicine

Location

Country

Kenya

Source

Source

International Finance Corporation (IFC)

URL

More Details

Record type

Project

Sector

Commercial, Hospital, Government

Article published date

2025-08-08

More on this project

Research

Free account

View all details

You are reading the public part. A free account opens the rest:

  • Every detail on this project
  • News and media coverage
  • Technical research
View all details

Free account · no card · lands you back on this project